LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹39 Cr | ₹76 Cr | ₹69 Cr | ₹75 Cr | ₹53 Cr |
What is the latest Cash Flow from Operating Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹39 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹69 Cr |
Mar2020 | ₹75 Cr |
Mar2019 | ₹53 Cr |
How is Cash Flow from Operating Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹39 Cr | -48.43 | |
Mar2022 | ₹76 Cr | 9.91 | |
Mar2021 | ₹69 Cr | -8.15 | |
Mar2020 | ₹75 Cr | 42.71 | |
Mar2019 | ₹53 Cr | - |
Compare Cash Flow from Operating Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,209.3 Cr | 2% | 2% | 52.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | 2% |
2% |
52.2% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses